Inhaled mannitol shifts exhaled nitric oxide in opposite directions in asthmatics and healthy subjects

被引:18
作者
Högman, M
Lúdvíksdóttir, D
Anderson, SD
George, S
Håkansson, L
Chan, HK
Meriläinen, P
Hedenström, H
机构
[1] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Akad Sjukhuset, Dept Resp Med & Allergol, Uppsala, Sweden
[3] Royal Prince Alfred Hosp, Dept Thorac Med, Camperdown, NSW 2050, Australia
[4] Univ Calif Irvine, Dept Chem & Biochem Engn & Mat Sci, Irvine, CA USA
[5] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[6] Univ Sydney, Dept Pharm, Sydney, NSW 2006, Australia
来源
RESPIRATION PHYSIOLOGY | 2001年 / 124卷 / 02期
关键词
disease; asthma; mammals; humans; mediator; NO; pharmacological agents; mannitol; upper airways; inflammation;
D O I
10.1016/S0034-5687(00)00195-X
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We investigated if healthy subjects could release NO upon hyperosmolar challenge as a defence mechanism, and whether asthmatics with atopy showed an altered response. A plot Of NO output versus ROW rate was used to calculate the alveolar level and the NO-flux from the airways. The asthmatics had a higher NO output and this was: due to an increased NO-flux from the airways, 86 +/- 30 nl min(-1) compared with control 21 +/- nl min(-1) (P < 0.05). The alveolar NO levels showed no difference. In response to a dry powder of mannitol the exhaled NO concentration decreased in asthmatics by 37 +/- 7%, but increased in the control by 9 +/- 4% (P < 0.001). The FEV1.0 decreased 13 +/- 2% and airway conductance 42 +/- 7% in asthmatics and in the controls 2 +/- 1% and 0 +/- 7%, respectively (P < 0.001). We conclude that asthmatics have an altered response to mannitol challenge in regards to exhaled NO. This may result from down regulation of constitutive NO production as a result of high levels of NO flux from the airways. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 31 条
  • [1] ALVING K, 1993, EUR RESPIR J, V6, P1368
  • [2] A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol
    Anderson, SD
    Brannan, J
    Spring, J
    Spalding, N
    Rodwell, LT
    Chan, K
    Gonda, I
    Walsh, A
    Clark, AR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) : 758 - 765
  • [3] Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma
    de Gouw, HWFM
    Hendriks, J
    Woltman, AM
    Twiss, IM
    Sterk, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) : 315 - 319
  • [4] DISASSOCIATION OF THE RELEASE OF HISTAMINE AND ARACHIDONIC-ACID METABOLITES FROM OSMOTICALLY ACTIVATED BASOPHILS AND HUMAN LUNG MAST-CELLS
    EGGLESTON, PA
    KAGEYSOBOTKA, A
    PROUD, D
    ADKINSON, NF
    LICHTENSTEIN, LM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (04): : 960 - 964
  • [5] VIRUS-INDUCED AIRWAY HYPERRESPONSIVENESS IN GUINEA RIGS IS RELATED TO A DEFICIENCY IN NITRIC-OXIDE
    FOLKERTS, G
    VANDERLINDE, HJ
    NIJKAMP, FP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) : 26 - 30
  • [6] MEDIATOR RELEASE IN AN ISOLATED AIRWAY SEGMENT IN SUBJECTS WITH ASTHMA
    GRAVELYN, TR
    PAN, PM
    ESCHENBACHER, WL
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (03): : 641 - 646
  • [7] Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness
    Henriksen, AH
    Sue-Chu, M
    Holmen, TL
    Langhammer, A
    Bjermer, L
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (02) : 301 - 306
  • [8] HOGMAN M, 1993, EUR RESPIR J, V6, P177
  • [9] HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474
  • [10] Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements
    Hogman, M
    Stromberg, S
    Schedin, U
    Frostell, C
    Hedenstierna, G
    Gustafsson, LE
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1997, 159 (04): : 345 - 346